PH11697A - Tertiary alcohol stabilized e-series prostaglandins - Google Patents

Tertiary alcohol stabilized e-series prostaglandins

Info

Publication number
PH11697A
PH11697A PH17025A PH17025A PH11697A PH 11697 A PH11697 A PH 11697A PH 17025 A PH17025 A PH 17025A PH 17025 A PH17025 A PH 17025A PH 11697 A PH11697 A PH 11697A
Authority
PH
Philippines
Prior art keywords
tertiary alcohol
series prostaglandins
alcohol stabilized
stabilized
prostaglandins
Prior art date
Application number
PH17025A
Other languages
English (en)
Inventor
D Monkhouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH11697A publication Critical patent/PH11697A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
PH17025A 1974-04-19 1975-04-07 Tertiary alcohol stabilized e-series prostaglandins PH11697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
PH11697A true PH11697A (en) 1978-05-24

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17025A PH11697A (en) 1974-04-19 1975-04-07 Tertiary alcohol stabilized e-series prostaglandins

Country Status (23)

Country Link
US (1) US3927197A (US07166745-20070123-C00016.png)
JP (1) JPS5337408B2 (US07166745-20070123-C00016.png)
AR (1) AR213271A1 (US07166745-20070123-C00016.png)
AT (1) AT348130B (US07166745-20070123-C00016.png)
AU (1) AU470631B2 (US07166745-20070123-C00016.png)
BE (1) BE828065A (US07166745-20070123-C00016.png)
BG (1) BG35326A3 (US07166745-20070123-C00016.png)
CA (1) CA1034044A (US07166745-20070123-C00016.png)
CS (1) CS191244B2 (US07166745-20070123-C00016.png)
DD (1) DD119131A5 (US07166745-20070123-C00016.png)
DE (1) DE2516105C3 (US07166745-20070123-C00016.png)
DK (1) DK138161B (US07166745-20070123-C00016.png)
ES (1) ES436613A1 (US07166745-20070123-C00016.png)
FI (1) FI62220C (US07166745-20070123-C00016.png)
FR (1) FR2267760B1 (US07166745-20070123-C00016.png)
GB (1) GB1474852A (US07166745-20070123-C00016.png)
HU (1) HU175405B (US07166745-20070123-C00016.png)
IE (1) IE40829B1 (US07166745-20070123-C00016.png)
IL (1) IL46994A (US07166745-20070123-C00016.png)
LU (1) LU72320A1 (US07166745-20070123-C00016.png)
NL (1) NL158384B (US07166745-20070123-C00016.png)
PH (1) PH11697A (US07166745-20070123-C00016.png)
SE (1) SE428528B (US07166745-20070123-C00016.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US07166745-20070123-C00016.png) 1976-03-17
JPS5337408B2 (US07166745-20070123-C00016.png) 1978-10-09
IE40829B1 (en) 1979-08-29
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
FI751108A (US07166745-20070123-C00016.png) 1975-10-20
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US07166745-20070123-C00016.png) 1975-10-20
JPS50145515A (US07166745-20070123-C00016.png) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US07166745-20070123-C00016.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US07166745-20070123-C00016.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (US07166745-20070123-C00016.png) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (US07166745-20070123-C00016.png) 1979-01-02

Similar Documents

Publication Publication Date Title
HK10378A (en) Current-source arrangement
IL47465A (en) Methyl 5-propylthio-2-benzimida-zolecarbamate
PH11697A (en) Tertiary alcohol stabilized e-series prostaglandins
HK16581A (en) Mould
AU8772775A (en) Prostaglandin analogous compounds
JPS5188901A (en) Futsusonyoru cc futsusoka
ZA75856B (en) Prostaglandin analogues
ZA752304B (en) Prostaglandin compositions
MY7800321A (en) Prostaglandins
AU8003775A (en) Prostaglandin analogues
AU7719475A (en) Prostaglandin analogues
ZA747723B (en) 11-desoxy-15-substituted-omega-pentanor prostaglandins
AU493932B2 (en) Novel prostaglandins
GB1523649A (en) Alcohol process
IE41596L (en) Over-cap
JPS5140161A (en) Rinia enkoodasochi
MY8000016A (en) Prostaglandins
ZA75199B (en) Spacer
ZA756742B (en) Prostaglandin analogues
JPS5159236A (en) Purintano busy shingohatsuseihoshiki
JPS5165306A (en) Rinia moota
JPS5145206A (en) Rinia moota
JPS5169110A (en) Rinia moota
JPS5145207A (en) Rinia moota
AU7639074A (en) Relays